Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model

Jason Gordon,Oliver Darlington,Phil McEwan,Matthew Lumley,Amer Taie,Meagen Hicks,Claudie Charbonneau,Angela Blake,Neil Hawkins,Simon Goldenberg,Jonathan Otter,Mark Wilcox
DOI: https://doi.org/10.1007/s40273-020-00906-6
2020-04-06
PharmacoEconomics
Abstract:Antimicrobial resistance (AMR) represents a significant threat to patient and population health. The study aim was to develop and validate a model of AMR that defines and quantifies the value of new antibiotics.
pharmacology & pharmacy,health care sciences & services,health policy & services,economics
What problem does this paper attempt to address?